Neurotech International Ltd has released a press release.
Reinstatement to Quotation
Filed with ASX ·
6ix hasn’t read this filing yet.
Neurotech International Ltd. on 6ix
In the deck
Story so far
Earlier from Neurotech International
- Suspension From Official Quotation
- 20 Week Data Shows Significant Improvement For ASD Children
- New Phase I/II Clinical Trial in Children with PANDAS/PANS
- Executive Change
- Q&A on NTI164 Breakthrough Clinical Trial Results in ASD
Later from Neurotech International
- Neurotech Receives $1.2M R&D Tax Rebate
- NTI Receives HREC/TGA Approval for Phase II/III ASD Trial
- Commencement of Phase II/III ASD Clinical Trial
- Disclosure Document
- NTI Granted FDA Pre-IND Meeting for NTI164 in ASD
Follow Neurotech International into a list and get an email when it puts out news.
Follow Neurotech International